Integrated Filing — IndAS



General information about company

Scrip Code 524037
NSE Symbol RAMAPHO
MSEI Symbol NOTLISTED
ISIN INE809A01032
Name of company RAMA PHOSPHATES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-10-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-10-2025   15:00:00
End date and time of board meeting 14-10-2025   17:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-05-2025
Indicate Company website link for updated RPT policy of the Company www.ramaphosphates.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 24,565.73 43,597.08
Other income 27.22 49.93
Total income 24,592.95 43,647.01
2 Expenses
(a) Cost of materials consumed 12,908.61 25,844.23
(b) Purchases of stock-in-trade 322.97 558.27
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 2,884.94 2,123.33
(d) Employee benefit expense 890.07 1,777.16
(e) Finance costs 221.15 572.94
(f) Depreciation, depletion and amortisation expense 200.05 395.09
(f) Other Expenses
1 Other Expenses 4,875.54 7,940.05
Total other expenses 4,875.54 7,940.05
Total expenses 22,303.33 39,211.07
3 Total profit before exceptional items and tax 2,289.62 4,435.94
4 Exceptional items 0.00 0.00
5 Total profit before tax 2,289.62 4,435.94
6 Tax expense
7 Current tax 606.80 778.02
8 Deferred tax (45.52) 326.26
9 Total tax expenses 561.28 1,104.28
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,728.34 3,331.66
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,728.34 3,331.66
17 Other comprehensive income net of taxes (9.46) (19.21)
18 Total Comprehensive Income for the period 1,718.88 3,312.45
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,767.43 1,767.43
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.88 9.42
Diluted earnings (loss) per share from continuing operations 4.88 9.42
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.88 9.42
Diluted earnings (loss) per share from continuing and discontinued operations 4.88 9.42
24 Debt equity ratio 0.25 0.25
25 Debt service coverage ratio 6.24 6.24
26 Interest service coverage ratio 11.35 11.35
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results have been reviewed by the Audit Committee and were taken on the record by the Board at their Board meeting held on 14th October 2025. The Statutory Auditor has carried out a Limited Review of the Unaudited Financial Result for the Quarter & Half year ended 30th September 2025. 2. The above results are prepared in compliance with Indian Accounting Standard Ind AS as prescribed under Section 133 of the Companies Act 2013 and notified by the Ministry of Corporate Affairs under the Companies Indian Accounting Standards Rules 2015 and amendments issued thereafter and other accounting principles generally accepted in India. 3. A. The Company is focused on two business segments Fertilizers Micro Nutrients and Chemicals and Soya Agri. Based on the management approach as defined in Ind AS 108 Operating Segments the Cheif Operating Decision Maker evaluates the Companys performance and allocates resources based on an analysis of various performance indicators by business segments. Accordingly information has been presented along these business segments. The accounting principles used in the preparation of the financial results are consistently applied to record revenue and expenditure in individual segments. 3. B. Segment results represents the profit or loss before interest and Tax charged by each segment without allocation of central administrative costs finance cost and other income. 4. The Board of Directors at its meeting held on November 13 2024 approved sub division split of the existing 1 One Equity Share of the Company having face value of Rs. 10 Rupees Ten Only each into 2 Two Equity Share having face value of Rs. 5 Rupees Five Only each and the same was approved by the Shareholders through Postal Ballot on January 1 2025. On and from the Record date February 7 2025 the sub ivision split became effective on both the stock exchanges i.e. BSE and NSE. Hence as prescribed under Ind AS the Company has presented basic and diluted earnings per share basis the new number of share for the current as well as previous periods. 5. The Company has received Environmental Clearance EC from Ministry of Environment Forest and Climate Change MOEF for its new Greenfield project at Dhule to manufacture of 216000 MT PA SSP Fertilizer and 90000 MT PA Sulphuric Acid. Accordingly Company is executing its schedule Phase 1 project to manufacture SSP Fertilizer and trial production is expected to commence by 4th quarter of FY 2026. 6.The Board of Directors have recommended an interim dividend of Rs 0.50 per Equity share 10 percent on face value of Rs. 5 per share. 7. The Company has extended and executed the lease agreement dated October 06 2025 for the manufacturing unit located at Nimbahera for a further period of five years Commencing from December 09 2026 to December 08 2031 between Arihant Phosphate and Fertilizers Ltd. and Rama Phosphates Limited the Company considering the past successful operation. 8. The Company does not have any Subsidiary company or Associate company or Joint Venture company as on 30th September 2025 and consequently the Company is not required to prepare consolidated financial results as per applicable laws and regulations. 9. The results of the Company are also available on stock exchange websites www.nseindia.com www.bseindia.com and on the Company website at www.ramaphosphates.com 10. Tax including Deferred Tax is accounted based on quarterly results and difference if any will be adjusted in the last quarter for annual tax or deferred tax. 11. The Company has long term credit rating ICRA A minus by ICRA. 12. Figures of the previous quarter period have been regrouped and rearranged where ever necessary to make them comparable.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 16,095.93
Capital work-in-progress 3,039.88
Investment property
Goodwill 0.00
Other intangible assets 11.84
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 39.09
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets 590.69
Total non-current financial assets 629.78
Deferred tax assets (net)
Other non-current assets 9.08
Total non-current assets 19,786.51
2 Current assets
Inventories 16,241.40
Current financial asset
Current investments 0.00
Trade receivables, current 7,531.85
Cash and cash equivalents 16.99
Bank balance other than cash and cash equivalents 1,109.44
Loans, current 21.32
Other current financial assets 15,232.11
Total current financial assets 23,911.71
Current tax assets (net)
Other current assets 4,474.29
Total current assets 44,627.40
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 64,413.91
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,767.43
Other equity 38,578.16
Total equity attributable to owners of parent 40,345.59
Non controlling interest
Total equity 40,345.59
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 97.31
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 127.16
Total non-current financial liabilities 224.47
Provisions, non-current 128.43
Deferred tax liabilities (net) 1,498.01
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 1,850.91
Current liabilities
Current financial liabilities
Borrowings, current 9,956.43
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,204.56
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 7,219.89
Total Trade payable 8,424.45
Other current financial liabilities 2,393.15
Total current financial liabilities 20,774.03
Other current liabilities 861.34
Provisions, current 220.29
Current tax liabilities (Net) 361.75
Deferred government grants, Current
Total current liabilities 22,217.41
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 24,068.32
Total equity and liabilites 64,413.91
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Fertilizers, Micro Nutrients & Chemicals 24,560.80 42,201.10
2 Soya/Agri 0.0000493 1,395.98
Total Segment Revenue 24,565.73 43,597.08
Less: Inter segment revenue
Revenue from operations 24,565.73 43,597.08
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Fertilizers, Micro Nutrients & Chemicals 2,765.14 5,518.81
2 Soya/Agri (57.98) (85.83)
Total Profit before tax 2,707.16 5,432.98
i. Finance cost 221.15 572.94
ii. Other Unallocable Expenditure net off Unallocable income 196.39 424.10
Profit before tax 2,289.62 4,435.94
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Fertilizers, Micro Nutrients & Chemicals 60,722.22 60,722.22
2 Soya/Agri 2,396.46 2,396.46
Total Segment Asset 63,118.68 63,118.68
Un-allocable Assets 1,295.23 1,295.23
Net Segment Asset 64,413.91 64,413.91
4 Segment Liabilities
Segment Liabilities
1 Fertilizers, Micro Nutrients & Chemicals 20,477.54 20,477.54
2 Soya/Agri 1,337.40 1,337.40
Total Segment Liabilities 21,814.94 21,814.94
Un-allocable Liabilities 2,253.38 2,253.38
Net Segment Liabilities 24,068.32 24,068.32
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) on defined benefit plan -1675000 -3351000
2 Gain / (Loss) on Fair Value of Investments 359000 685000
Total Amount of items that will not be reclassified to profit and loss (13.16) (26.66)
2 Income tax relating to items that will not be reclassified to profit or loss (3.70) (7.45)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (9.46) (19.21)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 4,435.94
Adjustments for reconcile profit (loss)
Adjustments for finance costs 572.94
Adjustments for decrease (increase) in inventories 4,656.29
Adjustments for decrease (increase) in trade receivables, current (1,509.28)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (673.48)
Adjustments for decrease (increase) in other non-current assets 2.69
Adjustments for other financial assets, non-current 5.72
Adjustments for other financial assets, current (3,504.34)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (1,795.84)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (23.76)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 395.09
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (21.45)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 1,134.10
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 37.20
Adjustments for dividend income 0.00
Adjustments for interest income 44.73
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 1.75
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (767.10)
Net cash flows from (used in) operations 3,668.84
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 418.54
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 3,250.30
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1.42
Purchase of property, plant and equipment 561.93
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 174.68
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 44.73
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 26.61
Net cash flows from (used in) investing activities (314.49)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 97.31
Repayments of borrowings 2,283.52
Payments of lease liabilities 102.24
Dividends paid 88.47
Interest paid 558.83
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (2,935.75)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 0.06
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 0.06
Cash and cash equivalents cash flow statement at beginning of period 16.93
Cash and cash equivalents cash flow statement at end of period 16.99





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Any other transaction Loan Received Approved by Audit Committee 1,125.00 0.00 0.00 Loan 9.00 180 days Unsecured Working Capital Requirement
2 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Any other transaction Loan Repaid Approved by Audit Committee 1,125.00 0.00 0.00
3 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 35.63 0.00 0.00
4 Rama Phosphates Limited JUPITER CORPORATE SERVICE PVT.LTD. Entities with joint control or significant influence over entity Any other transaction ICD taken Approved by Audit Committee 290.00 0.00 0.00
5 Rama Phosphates Limited JUPITER CORPORATE SERVICE PVT.LTD. Entities with joint control or significant influence over entity Any other transaction ICD Repaid Approved by Audit Committee 290.00 0.00 0.00
6 Rama Phosphates Limited JUPITER CORPORATE SERVICE PVT.LTD. Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 12.79 0.00 0.00
7 Rama Phosphates Limited RAINBOW AGRI INDUSTRIES LIMITED Entities with joint control or significant influence over entity Any other transaction ICD taken Approved by Audit Committee 375.00 0.00 0.00
8 Rama Phosphates Limited RAINBOW AGRI INDUSTRIES LIMITED Entities with joint control or significant influence over entity Any other transaction ICD Repaid Approved by Audit Committee 375.00 0.00 0.00
9 Rama Phosphates Limited RAINBOW AGRI INDUSTRIES LIMITED Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 12.52 0.00 0.00
10 Rama Phosphates Limited RAINBOW AGRI INDUSTRIES LIMITED Entities with joint control or significant influence over entity Any other transaction Receiving of Services (Rent Paid) Approved by Audit Committee 54.00 0.00 0.00
11 Rama Phosphates Limited Haresh Ramsinghani Key management personnel of entity Remuneration Approved by Audit Committee 70.00 0.00 0.00
12 Rama Phosphates Limited Jambu Kumar Parakh Key management personnel of entity Remuneration Approved by Audit Committee 88.80 0.00 0.00
13 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Remuneration Approved by Audit Committee 4.87 0.00 0.00
14 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Any other transaction Loan Repayment Approved by Audit Committee 1.00 6.00 5.00
15 Rama Phosphates Limited Nilanjana H Ramsinghani Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.30 0.00 0.00
16 Rama Phosphates Limited Naresh Verma Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.15 0.00 0.00
17 Rama Phosphates Limited Brij Lal Khanna Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.90 0.00 0.00
18 Rama Phosphates Limited Kishore P Sukhthankar Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.45 0.00 0.00
19 Rama Phosphates Limited Pushpangadan Mangari Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.45 0.00 0.00
20 Rama Phosphates Limited Ratneshwar Prasad Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.75 0.00 0.00
21 Rama Phosphates Limited RAMA PETROCHEMICALS LTD Entities with joint control or significant influence over entity Purchase of goods or services 6,032.00 Approved by Audit Committee 26.79 0.00 15.73 Textual Information(1)
Total value of transaction during the reporting period 3,889.40



Text Block

Textual Information(1) Every year fresh approval is taken


Format for Disclosing Outstanding Default on Loans and Debt Securities

Amount in (Lakhs)

<
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0.00